Baird Medical Investment (BDMD) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $0.57, -5.67% vs the prior close of $0.60.
- Volume 53.92K shares, 0.9x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
BDMD slides 5.7% to $0.57. Closed at $0.57, -5.67% vs the prior close of $0.60. Day range $0.55–$0.64, opened at $0.60.
BDMD daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — BDMD slides 5.7% to $0.57
- Closed at $0.57, -5.67% vs the prior close of $0.60. Day range $0.55–$0.64, opened at $0.60.
- Volume was 53.92K shares, 0.9x its 50-day average of 58.31K.
- Price is -41.9% vs its 50-day average ($0.97) and -59.1% vs its 200-day average ($1.38).
- 52-week range $0.51–$3.70; today's close sits at 2% of that range, 84.7% below the 52-week high.
Oct 15, 2026 — BDMD jumps 8.9% to $0.60
- Closed at $0.60, +8.89% vs the prior close of $0.55. Day range $0.55–$0.62, opened at $0.55.
- Volume was 80.00K shares, 1.4x its 50-day average of 57.20K.
- Price is -39.2% vs its 50-day average ($0.99) and -56.8% vs its 200-day average ($1.39).
- 52-week range $0.51–$3.70; today's close sits at 3% of that range, 83.8% below the 52-week high.
Oct 14, 2026 — BDMD slides 19.6% to $0.55, a 52-week low on 2.3x normal volume
- Closed at $0.55, -19.56% vs the prior close of $0.69. Day range $0.51–$0.71, opened at $0.69.
- Volume was 127.20K shares, 2.3x its 50-day average of 55.84K — unusually heavy trading.
- Price is -44.7% vs its 50-day average ($1.00) and -60.4% vs its 200-day average ($1.39).
- 52-week range $0.51–$3.70; today's close sits at 1% of that range, 85.1% below the 52-week high.
- That makes 5 straight losses.
Oct 13, 2026 — BDMD slides 8.7% to $0.69, a 52-week low, 4 down days in a row
- Closed at $0.69, -8.67% vs the prior close of $0.75. Day range $0.68–$0.73, opened at $0.68.
- Volume was 43.80K shares, 0.8x its 50-day average of 56.13K.
- Price is -32.0% vs its 50-day average ($1.01) and -50.9% vs its 200-day average ($1.40).
- 52-week range $0.66–$3.70; today's close sits at 1% of that range, 81.5% below the 52-week high.
- That makes 4 straight losses.
Oct 12, 2026 — BDMD dips 2.6% to $0.75, 3 down days in a row
- Closed at $0.75, -2.60% vs the prior close of $0.77. Day range $0.66–$0.80, opened at $0.74.
- Volume was 67.20K shares, 1.2x its 50-day average of 55.70K.
- Price is -26.1% vs its 50-day average ($1.01) and -46.4% vs its 200-day average ($1.40).
- 52-week range $0.66–$3.70; today's close sits at 3% of that range, 79.7% below the 52-week high.
- That makes 3 straight losses.
Oct 9, 2026 — BDMD dips 2.5% to $0.77
- Closed at $0.77, -2.53% vs the prior close of $0.79. Day range $0.76–$0.81, opened at $0.77.
- Volume was 50.10K shares, 0.9x its 50-day average of 55.65K.
- Price is -24.5% vs its 50-day average ($1.02) and -45.1% vs its 200-day average ($1.40).
- 52-week range $0.66–$3.70; today's close sits at 4% of that range, 79.2% below the 52-week high.
Oct 8, 2026 — BDMD ends flat (+0.0%) to $0.79
- Closed at $0.79, +0.00% vs the prior close of $0.79. Day range $0.77–$0.83, opened at $0.77.
- Volume was 67.00K shares, 1.2x its 50-day average of 54.84K.
- Price is -23.0% vs its 50-day average ($1.03) and -43.8% vs its 200-day average ($1.41).
- 52-week range $0.66–$3.70; today's close sits at 4% of that range, 78.6% below the 52-week high.
Oct 7, 2026 — BDMD rises 1.3% to $0.79
- Closed at $0.79, +1.28% vs the prior close of $0.78. Day range $0.74–$0.81, opened at $0.74.
- Volume was 64.50K shares, 1.2x its 50-day average of 54.44K.
- Price is -23.3% vs its 50-day average ($1.03) and -43.9% vs its 200-day average ($1.41).
- 52-week range $0.66–$3.70; today's close sits at 4% of that range, 78.6% below the 52-week high.
Oct 6, 2026 — BDMD jumps 5.0% to $0.78
- Closed at $0.78, +4.98% vs the prior close of $0.74. Day range $0.73–$0.80, opened at $0.73.
- Volume was 41.40K shares, 0.8x its 50-day average of 54.44K.
- Price is -24.7% vs its 50-day average ($1.04) and -44.8% vs its 200-day average ($1.41).
- 52-week range $0.66–$3.70; today's close sits at 4% of that range, 78.9% below the 52-week high.
Oct 5, 2026 — BDMD dips 1.1% to $0.74, a 52-week low
- Closed at $0.74, -1.07% vs the prior close of $0.75. Day range $0.74–$0.85, opened at $0.75.
- Volume was 51.90K shares, 1.0x its 50-day average of 54.17K.
- Price is -28.6% vs its 50-day average ($1.04) and -47.5% vs its 200-day average ($1.42).
- 52-week range $0.66–$3.70; today's close sits at 3% of that range, 79.9% below the 52-week high.
Oct 2, 2026 — BDMD rises 0.9% to $0.75
- Closed at $0.75, +0.94% vs the prior close of $0.74. Day range $0.73–$0.81, opened at $0.73.
- Volume was 48.90K shares, 0.9x its 50-day average of 53.61K.
- Price is -28.3% vs its 50-day average ($1.05) and -47.1% vs its 200-day average ($1.42).
- 52-week range $0.66–$3.70; today's close sits at 3% of that range, 79.7% below the 52-week high.
BDMD latest news & SEC filings
Every SEC filing by or about BDMD in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 1, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 30, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 30, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 24, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 3, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 18, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 17, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Aug 17, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Jul 31, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Jul 31, 2026 · Form SCHEDULE 13D — Activist-style stake (13D)
Activist-style stake (13D) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 27, 2026 · Form 20-F/A — 20-F/A filing
20-F/A filing
Things to know before you trade BDMD
- How much it moves: over the last 20 sessions the average daily move was 4.80% (largest 19.9%). That is a volatile stock.
- Liquidity: about 78.42K shares (≈$44.38K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.57 vs a range of $0.51–$3.70 (2% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Sep 30, 2026; 6-K Sep 30, 2026; 6-K Sep 3, 2026.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
BDMD market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.60 | 0.64 | 0.55 | 0.57 | 53.92K |
| Oct 15, 2026 | 0.55 | 0.62 | 0.55 | 0.60 | 80.00K |
| Oct 14, 2026 | 0.69 | 0.71 | 0.51 | 0.55 | 127.20K |
| Oct 13, 2026 | 0.68 | 0.73 | 0.68 | 0.69 | 43.80K |
| Oct 12, 2026 | 0.74 | 0.80 | 0.66 | 0.75 | 67.20K |
| Oct 9, 2026 | 0.77 | 0.81 | 0.76 | 0.77 | 50.10K |
| Oct 8, 2026 | 0.77 | 0.83 | 0.77 | 0.79 | 67.00K |
| Oct 7, 2026 | 0.74 | 0.81 | 0.74 | 0.79 | 64.50K |
| Oct 6, 2026 | 0.73 | 0.80 | 0.73 | 0.78 | 41.40K |
| Oct 5, 2026 | 0.75 | 0.85 | 0.74 | 0.74 | 51.90K |
| Oct 2, 2026 | 0.73 | 0.81 | 0.73 | 0.75 | 48.90K |
| Oct 1, 2026 | 0.77 | 0.82 | 0.74 | 0.74 | 57.00K |
| Sep 30, 2026 | 0.76 | 0.80 | 0.73 | 0.78 | 57.80K |
| Sep 29, 2026 | 0.74 | 0.85 | 0.73 | 0.80 | 18.20K |
| Sep 28, 2026 | 0.74 | 0.88 | 0.74 | 0.77 | 46.10K |
| Sep 25, 2026 | 0.76 | 0.82 | 0.73 | 0.77 | 50.00K |
| Sep 24, 2026 | 0.79 | 0.80 | 0.75 | 0.78 | 25.40K |
| Sep 23, 2026 | 0.77 | 0.82 | 0.73 | 0.79 | 187.90K |
| Sep 22, 2026 | 0.83 | 0.92 | 0.66 | 0.79 | 226.10K |
| Sep 21, 2026 | 1.02 | 1.04 | 0.74 | 0.84 | 203.90K |
About Baird Medical Investment
Baird Medical Investment (BDMD) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in SHEUNG WAN. State of incorporation: Cayman Islands. Fiscal year ends December 31. SEC CIK 1982444.
BDMD board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Gabrielle Bilciu-Wolfson | Director | Apr 17, 2026 |
| Wei Hou | Director | Mar 31, 2026 |
| Quan Qiu | Director | Apr 21, 2026 |
| Joseph Douglas Iii Ragan | Director | Mar 31, 2026 |
| Haimei Wu | Director | Mar 27, 2026 |
| Lijian Xu | Director | Apr 21, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Jie Clara Li | Acting Chief Financial Officer | Apr 15, 2026 |
| Rongjian Lu | Chief Technical Officer | Apr 21, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
BDMD financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
BDMD earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on BDMD
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.